These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. Ghadirian AM; Annable L; Bélanger MC; Chouinard G J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543 [TBL] [Abstract][Full Text] [Related]
45. Drug induced parkinsonism: a common cause of parkinsonism in older people. Thanvi B; Treadwell S Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308 [TBL] [Abstract][Full Text] [Related]
50. A successful clonazepam treatment without tolerance in a patient with spontaneous oral dyskinesia. Fukasawa T; Takahashi M; Otani K Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1477-80. PubMed ID: 11513361 [TBL] [Abstract][Full Text] [Related]
51. Effect of donepezil on tardive dyskinesia. Ogunmefun A; Hasnain M; Alam A; Osuala T; Regenold WT J Clin Psychopharmacol; 2009 Feb; 29(1):102-4. PubMed ID: 19142126 [No Abstract] [Full Text] [Related]
52. Clozapine-induced tardive dyskinesia: a case report. Ertugrul A; Demir B Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369 [TBL] [Abstract][Full Text] [Related]
54. [Utility of quetiapine in tardive dyskinesia]. Navarro Pacheco BV; Montejo González AL; Martín Carrasco M Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511 [TBL] [Abstract][Full Text] [Related]
55. [Tardive dyskinesia: etiology, clinical features and therapy]. Furer V; Lichtenberg P; Heresco-Levy U Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354 [No Abstract] [Full Text] [Related]
56. [Neuroleptics and nicotine]. Erdmann R Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751 [TBL] [Abstract][Full Text] [Related]
57. The pharmacotherapy of Tourette syndrome. Caine ED Int J Neurol; 1980; 14(1):123-6. PubMed ID: 6959970 [No Abstract] [Full Text] [Related]
58. Current views on tardive dyskinesia. Gerlach J Pharmacopsychiatry; 1991 Mar; 24(2):47-8. PubMed ID: 1852791 [No Abstract] [Full Text] [Related]
59. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset. Pearce RK; Banerji T; Jenner P; Marsden CD Mov Disord; 1998 Mar; 13(2):234-41. PubMed ID: 9539335 [TBL] [Abstract][Full Text] [Related]
60. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia. Looper KJ; Chouinard G Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]